Form 4: SpringWorks Therapeutics Executive Receives Stock Options and Restricted Stock Units
SEC Form 4 Filing
James Cassidy, Chief Medical Officer of SpringWorks Therapeutics, reports the acquisition of stock options and restricted stock units.
Summary
- On January 10, 2025, James Cassidy, the Chief Medical Officer of SpringWorks Therapeutics, received 17,323 restricted stock units (RSUs) and options to purchase 50,615 shares of common stock.
- The RSUs vest in three tranches: 33% on January 10, 2026, 33% on January 10, 2027, and 34% on January 10, 2028, contingent upon continued service.
- The stock options vest in 48 equal monthly installments starting January 10, 2025, also subject to continued service.
- Following these transactions, Cassidy directly owns 81,731 shares of SpringWorks Therapeutics common stock and options to purchase 50,615 shares.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. The grant of equity aligns management with shareholder interests, which is generally viewed favorably. There are no indications of negative performance or concerns.
Positives
- The grant of RSUs and stock options aligns the executive's interests with those of the shareholders, incentivizing continued service and performance.
- The vesting schedules for both RSUs and stock options encourage long-term commitment from the Chief Medical Officer.
Future Outlook
The document does not contain specific forward-looking statements beyond the vesting schedules of the RSUs and stock options.
Industry Context
Grants of stock options and restricted stock units are common practices in the pharmaceutical industry to attract, retain, and incentivize key executives.
Stakeholder Impact
- Shareholders may view the equity grants positively as they align management's interests with the company's long-term success.
- Employees may see this as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 01/10/2025 | Date of transaction: Grant of RSUs and stock options. |
| 01/10/2025 | Stock options vest in 48 equal monthly installments following this date. |
| 01/10/2026 | First vesting date for 33% of the RSUs. |
| 01/10/2027 | Second vesting date for 33% of the RSUs. |
| 01/10/2028 | Final vesting date for 34% of the RSUs. |
| 01/10/2035 | Expiration date of the stock options. |
| 01/14/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.